Cancer cachexia is a wasting syndrome, which is characterized by weight loss, anorexia (loss of desire to eat), asthenia and anemia. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors.
It occurs in patients with advanced cancer, chronic obstructive pulmonary disease, chronic infection including AIDS and tuberculosis, chronic heart failure, and rheumatoid arthritis. However, the occurrence of cancer cachexia is high, especially in patients with advanced cancer, this syndrome often remains underdiagnosed.
DelveInsight's "Cancer Cachexia Market Insights, Epidemiology, and Market Forecast 2030" report delivers an in-depth understanding of the Cancer Cachexia, historical and forecasted epidemiology as well as the Cancer Cachexia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Cancer Cachexia market report also covers emerging drugs, current treatment practices, Cancer Cachexia market share of the individual therapies, current and forecasted Cancer Cachexia Market Size from 2017 to 2030 segmented by seven major markets. The report provides a detailed current Cancer Cachexia treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Cancer Cachexia Market Key Facts
- cachexia occurs in the majority of terminal cancer patients and is responsible for the death of 22% of cancer patients [As per a Japanese study conducted by Aoyagi et al.].
-
Among late stage patients, cachexia affects 50–80% of cancer patients
-
According to a study conducted by Advani et al., “cancer cachexia impacts approximately 60% of the 1.4 million patients diagnosed with cancer in the United States each year.
Key Benefits of Cancer Cachexia Market Report
-
Cancer Cachexia market report provides an in-depth analysis of Cancer Cachexia Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
-
The Cancer Cachexia market report will help in developing business strategies by understanding the Cancer Cachexia Market trends & developments, key players and future market competition that will shape and drive the Cancer Cachexia market in the upcoming years.
-
The Cancer Cachexia market report covers Cancer Cachexia current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
-
The report provides a detailed assessment of the Cancer Cachexia market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Cancer Cachexia Market Insight
The Cancer Cachexia market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Cancer Cachexia market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Cancer Cachexia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Cancer Cachexia Epidemiology Analysis
The Cancer Cachexia epidemiology section covers insights about historical and current Cancer Cachexia patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Cancer Cachexia Pipeline Analysis and Key Companies
The Cancer Cachexia Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cancer Cachexia market or expected to get launched in the market during the study period. The analysis covers Cancer Cachexia market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
For more detailed information on Cancer Cachexia Market visit: https://www.delveinsight.com/report-store/Cancer-cachexia-CC-market-insights